Delivery Order SPE2DB22D2211-SPE2DB24FPDZ0

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,077.38 firm fixed-price contract is for the delivery of 4,558,921,410 units of the contraceptive medication LO LOESTRIN FE 1-10 Tablet 28s. The contract has an ultimate completion date of October 31, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,416.59 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp by DLA to supply a range of pharmaceutical products and medical supplies to DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,736.37 award is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a branded oral contraceptive medication. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential...
This federal contract award is a $1,155.74 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, for the supply of Lo Loestrin FE 1-10 tablet 28s. The delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corp and DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to provide pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The contract has a ceiling value of $5,612.35 and is a firm fixed price contract type. The delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order, valued at $7,239.65, is for the supply of the medication Lo Loestrin Fe 1-10 Tablet 28s. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
This is a $10,190.37 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of LO LOESTRIN FE 1-10 tablet 28s, a contraceptive medication, with a period of performance through July 1, 2024. The contract was not set aside for any small business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $4,584.42, is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. This order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,098.24 firm-fixed-price contract is for the provision of Lo Loestrin Fe 1-10 tablet 28s, a birth control medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company. The contract, valued at $2,143.74, is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a brand-name oral contraceptive medication. The contract is a firm fixed price, with a performance period through March 11, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as the prime...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPDZ0
    Delivery Order

This is a $1,714.30 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,503,825 units of the contraceptive medication LO LOESTRIN FE 1-10 TABLET 28S. The delivery order does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This contract award is aligned with DLA's role in providing critical medical commodities to the U.S. Department of Defense and other federal healthcare providers.

Generated 11/18/24, 9:29 AM